Methamphetamine

Methamphetamine

SCHEMBL18985124

CCO.CN[C@@H](C)Cc1ccccc1

nearest known ligand 0.84

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Methamphetamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
SLC6A4 known ✓ P31645 2/20 0.53
SIGMAR1 Q99720 7/20 0.84
TAAR1 Q96RJ0 3/20 0.84
SLC18A2 Q05940 1/20 0.84
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
TRPA1 O75762 1/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methamphetamine SCHEMBL28959450 1.00 SIGMAR1 (0.84) SIGMAR1TAAR1SLC18A2NPC1RAB9A
Methamphetamine SCHEMBL27438559 0.94 SIGMAR1 (0.95) SIGMAR1TAAR1SLC18A2NPC1RAB9A
Methamphetamine SCHEMBL18227057 0.92 SIGMAR1 (0.91) SIGMAR1TAAR1SLC18A2NPC1RAB9A
Methamphetamine SCHEMBL13747483 0.92 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2NPC1RAB9A
Methamphetamine SCHEMBL15094315 0.92 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2NPC1RAB9A
Methamphetamine SCHEMBL42178 0.92 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2NPC1RAB9A
Methamphetamine SCHEMBL4781849 0.92 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2NPC1RAB9A
Methamphetamine SCHEMBL20211416 0.92 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2NPC1RAB9A
Methamphetamine SCHEMBL42615 0.92 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2NPC1RAB9A
Levmetamfetamine SCHEMBL727412 0.92 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190000834-A1 INJECTABLE COMPOSITION AND A METHOD OF TREATMENT OF THE PHYSICAL ADDICTION VERITA RESEARCH PTE LTD (AU) 2019-01-03 US disclosed
WO-2017100863-A1 INJECTABLE COMPOSITION AND A METHOD OF TREATMENT OF THE PHYSICAL ADDICTION VERITA RESEARCH PTE LTD (AU) 2017-06-22 WO disclosed